vs
Side-by-side financial comparison of SYPRIS SOLUTIONS INC (SYPR) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $30.3M, roughly 1.9× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -246.8%, a 233.9% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -9.5%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs -7.7%).
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
SYPR vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.3M | $57.2M |
| Net Profit | $-3.9M | $-141.2M |
| Gross Margin | 4.6% | — |
| Operating Margin | -10.9% | -70.5% |
| Net Margin | -12.9% | -246.8% |
| Revenue YoY | -9.5% | 7.6% |
| Net Profit YoY | -2992.6% | -2774.3% |
| EPS (diluted) | $-0.17 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | $57.2M | ||
| Q3 25 | $28.7M | $56.3M | ||
| Q2 25 | $31.4M | $52.6M | ||
| Q1 25 | $29.5M | $50.0M | ||
| Q4 24 | $33.4M | $53.2M | ||
| Q3 24 | $35.7M | $47.7M | ||
| Q2 24 | $35.5M | $50.5M | ||
| Q1 24 | $35.6M | $47.5M |
| Q4 25 | $-3.9M | $-141.2M | ||
| Q3 25 | $517.0K | $-22.6M | ||
| Q2 25 | $-2.1M | $-27.2M | ||
| Q1 25 | $-899.0K | $-29.5M | ||
| Q4 24 | $135.0K | $-4.9M | ||
| Q3 24 | $390.0K | $-5.3M | ||
| Q2 24 | $16.0K | $-4.5M | ||
| Q1 24 | $-2.2M | $-4.1M |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 16.1% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 15.9% | — | ||
| Q1 24 | 8.1% | — |
| Q4 25 | -10.9% | -70.5% | ||
| Q3 25 | -6.1% | -55.6% | ||
| Q2 25 | -4.6% | -73.2% | ||
| Q1 25 | -0.4% | -82.0% | ||
| Q4 24 | 3.9% | -19.3% | ||
| Q3 24 | 4.8% | -23.1% | ||
| Q2 24 | 3.6% | -20.1% | ||
| Q1 24 | -3.9% | -19.5% |
| Q4 25 | -12.9% | -246.8% | ||
| Q3 25 | 1.8% | -40.1% | ||
| Q2 25 | -6.5% | -51.7% | ||
| Q1 25 | -3.0% | -58.9% | ||
| Q4 24 | 0.4% | -9.2% | ||
| Q3 24 | 1.1% | -11.2% | ||
| Q2 24 | 0.0% | -9.0% | ||
| Q1 24 | -6.2% | -8.7% |
| Q4 25 | $-0.17 | $-2.40 | ||
| Q3 25 | $0.02 | $-0.38 | ||
| Q2 25 | $-0.09 | $-0.46 | ||
| Q1 25 | $-0.04 | $-0.50 | ||
| Q4 24 | $0.00 | $-0.09 | ||
| Q3 24 | $0.02 | $-0.09 | ||
| Q2 24 | $0.00 | $-0.08 | ||
| Q1 24 | $-0.10 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.8M | $327.2M |
| Total Assets | $107.8M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | $17.8M | $327.2M | ||
| Q3 25 | $20.0M | $466.0M | ||
| Q2 25 | $18.7M | $486.3M | ||
| Q1 25 | $19.0M | $511.4M | ||
| Q4 24 | $19.6M | $538.5M | ||
| Q3 24 | $18.2M | $541.2M | ||
| Q2 24 | $19.0M | $542.5M | ||
| Q1 24 | $20.8M | $544.0M |
| Q4 25 | $107.8M | $488.9M | ||
| Q3 25 | $112.5M | $601.1M | ||
| Q2 25 | $105.8M | $624.7M | ||
| Q1 25 | $110.2M | $631.9M | ||
| Q4 24 | $119.4M | $656.2M | ||
| Q3 24 | $121.6M | $645.1M | ||
| Q2 24 | $124.2M | $651.4M | ||
| Q1 24 | $129.0M | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-29.4M |
| Free Cash FlowOCF − Capex | $-1.5M | $-29.5M |
| FCF MarginFCF / Revenue | -5.0% | -51.6% |
| Capex IntensityCapex / Revenue | 1.3% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.5M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $-29.4M | ||
| Q3 25 | $-178.0K | $-31.6M | ||
| Q2 25 | $1.1M | $-15.3M | ||
| Q1 25 | $-5.5M | $-33.1M | ||
| Q4 24 | $2.3M | $-1.8M | ||
| Q3 24 | $-4.8M | $-14.6M | ||
| Q2 24 | $6.2M | $-6.9M | ||
| Q1 24 | $-1.7M | $7.6M |
| Q4 25 | $-1.5M | $-29.5M | ||
| Q3 25 | $-390.0K | $-31.8M | ||
| Q2 25 | $941.0K | $-15.6M | ||
| Q1 25 | $-5.5M | $-33.6M | ||
| Q4 24 | $1.9M | $-2.0M | ||
| Q3 24 | $-4.9M | $-14.7M | ||
| Q2 24 | $6.0M | $-7.0M | ||
| Q1 24 | $-2.0M | $7.6M |
| Q4 25 | -5.0% | -51.6% | ||
| Q3 25 | -1.4% | -56.5% | ||
| Q2 25 | 3.0% | -29.6% | ||
| Q1 25 | -18.8% | -67.1% | ||
| Q4 24 | 5.7% | -3.8% | ||
| Q3 24 | -13.8% | -30.9% | ||
| Q2 24 | 16.8% | -13.9% | ||
| Q1 24 | -5.7% | 15.9% |
| Q4 25 | 1.3% | 0.2% | ||
| Q3 25 | 0.7% | 0.3% | ||
| Q2 25 | 0.5% | 0.6% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 1.2% | 0.4% | ||
| Q3 24 | 0.4% | 0.3% | ||
| Q2 24 | 0.5% | 0.2% | ||
| Q1 24 | 0.9% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 17.13× | — | ||
| Q3 24 | -12.21× | — | ||
| Q2 24 | 385.25× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
